Gerald Horan

Gerald Horan

Company: Bristol Myers Squibb

Job title: Senior Director


Deep Diving into Biomarker Results From a Phase 2 Study of the CC-90001 JNK Inhibitor in NASH with Advanced Fibrosis 1:20 pm

Exploring how biomarkers can inform on mechanisms of fibrosis Treatment of F3 NASH Subjects with the CC-90001 JNK inhibitor associated with dose-dependent reductions in multiple biomarkers of fibrosis, including ELF and PRO-C3 Dose-dependent reductions in imaging MRE score were consistent with serum fibrosis biomarker results Effects of CC-90001 appeared to be mostly anti-fibrotic with little…Read more

day: Conf Day 1 Track 1 PM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.